Constrained Peptide Drugs Market By Application (Institutes of Biology, Hospitals, and Others), By Type (Disulfide-Rich Peptides (DRPs) and Cyclic Peptides), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 – 2032

The global constrained peptide drugs market size was valued $1,243.56 Mn in 2023 and anticipates growing to $4,374.69 Mn by 2032 at a CAGR of 15%.

2023年，全球限制性多肽药物市场规模达到了12.4356亿美元，预计到2032年将增长至43.7469亿美元，年复合增长率（CAGR）为15%。